Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA) paves the way for ISM8969 clinical ...

Controlling symptoms and maintaining mobility is currently the hallmark of managing patients with Parkinson's disease.

After three years of study, the researchers found that alpha-synuclein, a protein closely linked to Parkinson’s disease, forms an abnormal connection with an enzyme called ClpP. This enzyme normally ...

It’s the fastest-growing neurological disease in the world, and cases of Parkinson’s disease are only tipped to rise further ...

The combination of auditory and olfactory hallucinations is suggestive of a neurological disorder, such as Parkinson’s ...

Both his neurologist and primary care physician have assured him he does not have Parkinson's or LBD, but are they correct?

I am an 88-year-old widower. My wife died six years ago. I live alone, care for myself, drive, and consider myself healthy. I take five prescription meds and seven over-the-counter meds, three of ...

ANSWER: The combination of auditory and olfactory hallucinations is suggestive of a neurological disorder, such as ...

Abnormal clumps of proteins like α-synuclein, amyloid beta and tau are associated with neurodegenerative conditions like ...

FDA fast-tracks novel Parkinson’s cell therapy NouvNeu001, advancing treatment for dopaminergic neuron loss and motor ...

In people with Parkinson's disease, dysphagia is usually treated first with medicines that aim to improve the symptoms of Parkinson’s disease overall. If swallowing problems continue, rehabilitation ...

Insilico Medicine and Hygtia Therapeutics, an incubatee of Shenzhen Pengfu Fund of Fosun Health Capital and Fosun Pharma, have entered into an exclusive license and co-development collaboration to ...